National Advertising Division’s Updated Procedures Allow Reopening Of Old Cases
This article was originally published in The Rose Sheet
Marketers now can petition NAD to reopen cases if they have new studies or other data supporting ad claims that were shot down by the watchdog group previously, though the bar for re-review is high, says NAD Director Laura Brett.
You may also be interested in...
Arcadia prohibited from arguing against Advantice’s appeal of National Advertising Division decision that Kerasal Fungal Nail Renewal ad claims weren’t supported. Arcadia violated confidentiality rule by publicizing NAD decision before the review was officially closed.
New Jersey-based Arcadia Consumer Healthcare, Inc., succeeded in reopening a 2018 National Advertising Division case involving its ‘#1 Pharmacist Recommended’ claim for the Fungi-Nail line, but failed again to convince the NAD that survey findings justify the claim.
The National Advertising Division is weary of companies claiming confidentiality in its dispute resolution forum without adequately detailed cause or earnest efforts to meet the option’s requirements. A panel at the group’s annual meeting discussed the issue and steps advertisers should take to protect their competitive interests without compromising themselves or the self-regulatory system.